STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on May 15, 2025

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales force PEMGARDA revenue re-acceleration observed in Q2 2025 to date Invivyd continues to …

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Updated clinical data from Emi-Le Phase 1 dose escalation and backfill cohorts presented today at ESMO Breast Cancer 2025 ORR increased to 31% across tumor types among evaluable patients with B7-H4 high tumors receiving intermediate doses Encouraging …

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating …

Annual Report and Notice of Meeting

Annual Report and Notice of Meeting

Reykjavík, May 15, 2025 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Annual Report and Notice of Meeting TORONTO, ONTARIO – May 15, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a substantial …

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT

LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, announced that today it will unveil new preclinical proof-of-concept data for novelly …

CRN Recognizes Nine Climb Channel Solutions Employees on the 2025 ‘Women of the Channel’ List and Names Climb CMO Kim Stevens as one of the 2025 Women of the Channel Power 100

CRN Recognizes Nine Climb Channel Solutions Employees on the 2025 ‘Women of the Channel’ List and Names Climb CMO Kim Stevens as one of the 2025 Women of the Channel Power 100

EATONTOWN, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announced Monday, May 13, 2025 that CRN®, a brand of …

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

SAN FRANCISCO, May 15, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …

Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer

Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer

Two independent Phase 2 trials demonstrate extended progression-free survival in patients without TP53 mutations or without liver metastases Results presented at 2025 ESMO Breast Cancer Annual Congress BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Carrick …

Verde Announces Q1 2025 Results

Verde Announces Q1 2025 Results

(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q1 2025: C$1.00 = R$3.93) SINGAPORE, May 15, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the …

Sumanth Channabasappa Brings Industry-Defining Technology Expertise to Vetty

Sumanth Channabasappa Brings Industry-Defining Technology Expertise to Vetty

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop hiring acceleration platform, announced that Sumanth Channabasappa has joined the company effective May 5, 2025. An entrepreneur, growth strategist, product and technology leader and …

Salary.com Brings Compensation Technology Insights to WorldatWork Total Rewards ‘25

Salary.com Brings Compensation Technology Insights to WorldatWork Total Rewards ‘25

WALTHAM, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- WHO:     Salary.com, a leading provider of compensation market data and software         WHAT:     Will exhibit and present compensation insights during WorldatWork Total Rewards ‘25.         WHEN:     The …

Next Hydrogen Reports Q1 2025 Financial Results

Next Hydrogen Reports Q1 2025 Financial Results

MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen”) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to report its financial results for the three-month …

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

       – Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. …

Aya Gold & Silver Publishes 2024 Sustainability Report

Aya Gold & Silver Publishes 2024 Sustainability Report

MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that is has published its 2024 Sustainability Report for the year ended December 31, 2024 (the “Report”). The …

AAFA Calls for Comprehensive Reform to Make Medicines Accessible and Affordable for All

AAFA Calls for Comprehensive Reform to Make Medicines Accessible and Affordable for All

Washington, DC, May 15, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) appreciates the President’s Executive Order calling attention to America’s persistent problem of unaffordable prescription medicines. Our research tells us …

SYLOGIST Reports First Quarter 2025 Results

SYLOGIST Reports First Quarter 2025 Results

Q1 2025 Highlights1               Revenue (in $ millions)   SaaS Subscription Recurring Total Reported Y/Y growth Reported Y/Y growth Reported Y/Y growth $7.8 15% $10.9 6% $16.3 3%   SaaS ARR up 15% Y/Y to $31.4 million; ARR up 6% Y/Y to $44.3 million; …

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

Prioritization of givastomig as I-Mab’s lead program positions the Company for clinical progress New givastomig combination data selected for mini-oral presentation at ESMO GI, being held July 2-5 in Barcelona, Spain Strong financial position supported by …

Xtract One Enters Master Supply Agreement with Global Entertainment Organization for Security Screening Deployment

Xtract One Enters Master Supply Agreement with Global Entertainment Organization for Security Screening Deployment

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced that the Company has entered into a Master Supply Agreement with a new customer, a leading global media …

L’usine pilote du Réacteur de Silice Pyrogénée de HPQ franchit un jalon important en produisant un volume significatif de matériaux

L’usine pilote du Réacteur de Silice Pyrogénée de HPQ franchit un jalon important en produisant un volume significatif de matériaux

MONTRÉAL, 15 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans le développement de nouveaux procédés industriels souhaite informer ses actionnaires …

HPQ Fumed Silica Pilot Produces Significant Material Volumes in Key Milestone

HPQ Fumed Silica Pilot Produces Significant Material Volumes in Key Milestone

MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, would like to inform shareholders that …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service